| Impact of geographic origin on access to therapy and therapy outcomes in the Swiss Hepatitis C Cohort Study | PLOS ONE |  | | 2019 | 471 | 234 |
|
| Microelimination of chronic hepatitis C in Switzerland: modelling the Swiss Hepatitis Strategy goals in eastern, western and northern regions | Swiss Medical Weekly | | | 2019 | 444 | 335 |
|
| Progress toward implementing the Swiss Hepatitis Strategy: Is HCV elimination possible by 2030? | PLOS ONE | | | 2018 | 431 | 240 |
|
| Effect of hepatitis B virus on steatosis in hepatitis C virus co-infected subjects: A multi-centre study and systematic review | Journal of Viral Hepatitis |  | | 2018 | 536 | 0 |
|
| Visualization of hepatitis E virus RNA and proteins in the human liver | Journal of hepatology | | | 2017 | 467 | 0 |
|
| Geoepidemiology of Primary Biliary Cholangitis: Lessons from Switzerland | Clinical Reviews in Allergy & Immunology | | | 2017 | 525 | 0 |
|
| Hepatitis C virus dynamics among intravenous drug users suggest that an annual treatment uptake above 10% would eliminate the disease by 2030 | Swiss Medical Weekly | | | 2017 | 947 | 256 |
|
| A Systematic Review and Meta-Analysis of HCV Clearance | Liver international | | | 2017 | 608 | 1 |
|
| Trends in hepatitis C-related mortality in Switzerland | Journal of Hepatology | | | 2017 | 1,258 | 894 |
|
| Corrigendum: reduced IFNλ4 activity is associated with improved HCV clearance and reduced expression of interferon-stimulated genes | Nature communications | | | 2015 | 586 | 179 |
|
| Modeling the Health and Economic Burden of Hepatitis C Virus in Switzerland | PloS one | | | 2015 | 623 | 1,401 |
|
| Birth cohort distribution and screening for viraemic hepatitis C virus infections in Switzerland | Schweizerische medizinische Wochenschrift | | | 2015 | 616 | 259 |
|
| Clinical significance of the CCR5delta32 allele in hepatitis C | PloS one | | | 2014 | 590 | 270 |
|
| Historical epidemiology of hepatitis C virus (HCV) in selected countries | Journal of viral hepatitis | | | 2014 | 631 | 1 |
|
| The present and future disease burden of hepatitis C virus (HCV) infection with today's treatment paradigm | Journal of viral hepatitis | | | 2014 | 600 | 1 |
|
| Reduced IFNλ4 activity is associated with improved HCV clearance and reduced expression of interferon-stimulated genes | Nature communications | | | 2014 | 683 | 1,257 |
|
| Strategies to manage hepatitis C virus (HCV) disease burden | Journal of viral hepatitis | | | 2014 | 605 | 1 |
|
| Genetic analyses reveal a role for vitamin D insufficiency in HCV-associated hepatocellular carcinoma development | PloS one | | | 2013 | 713 | 657 |
|
| Comparative genetic analyses point to HCP5 as susceptibility locus for HCV-associated hepatocellular carcinoma | Journal of hepatology | | | 2013 | 676 | 0 |
|
| Genome-wide association study identifies variants associated with progression of liver fibrosis from HCV infection | Gastroenterology | | | 2012 | 635 | 0 |
|
| Characteristics of patients with chronic hepatitis C who develop hepatocellular carcinoma | Schweizerische medizinische Wochenschrift | | | 2012 | 567 | 0 |
|
